DR REDDYS LABS ADR/1 IR 5
DR REDDYS LABS ADR/1 IR 5
Certificat de dépôt · US2561352038 · RDY · 659157 (XNYS)
Aperçu
15,54 USD
0,91 % 0,14 USD
NYSE (XNYS) · Cours et graphiques actuels sur MoneyPeak
06.06.2025 19:59

Cours actuels de DR REDDYS LABS ADR/1 IR 5

BourseTickerDeviseDernier échangeCoursVariation journalière
XNYS: NYSE
NYSE
RDY
USD
06.06.2025 19:59
15,54 USD
15,53 USD
+0,06 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % 5,64 % 15,15 % 19,63 % 6,58 % 10,45 % -70,70 %

Firmenprofil zu DR REDDYS LABS ADR/1 IR 5 Hinterlegungsschein

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. Its Proprietary Products segment focuses on the research and development of differentiated formulations. The Others segment engages in developing therapies in the fields of oncology and inflammation. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. The company has a collaboration, license, and option agreement with Curis, Inc. to discover, develop, and commercialize small molecule antagonists for immuno-oncology and precision oncology targets. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Unternehmensdaten

Name DR REDDYS LABS ADR/1 IR 5
Firma Dr. Reddy's Laboratories Limited
Symbol RDY
Website https://www.drreddys.com
Heimatbörse XNYS NYSE
WKN 659157
ISIN US2561352038
Wertpapierart Hinterlegungsschein
Sektor Healthcare
Branche Drug Manufacturers - Specialty & Generic
CEO Mr. Erez Israeli M.B.A.
Marktkapitalisierung 11 Mrd.
Land Indien
Währung USD
Mitarbeiter 27,0 T
Adresse 8-2-337, Road No. 3, 500034 Hyderabad
IPO Datum 2001-04-11

Aktien-Splits

Datum Split
05.11.2024 5:1
07.09.2006 2:1

Ticker Symbole

Name Symbol
Frankfurt RDDA.F
NYSE RDY

Weitere Aktien

Investoren die DR REDDYS LABS ADR/1 IR 5 die halten, haben auch folgende Aktien im Depot:
AMAZON.CO INC
AMAZON.CO INC Aktie
APPLE INC
APPLE INC Aktie
CAMECO
CAMECO Aktie
DEUTSCHE POST AG
DEUTSCHE POST AG Aktie
HESSEN SCHA.22/29
HESSEN SCHA.22/29 Anleihe
HUGO BOSS
HUGO BOSS Aktie
LB.HESS.-THR. PF. 24/27
LB.HESS.-THR. PF. 24/27 Anleihe
MICROSOFT CORP
MICROSOFT CORP Aktie
NETFLIX INC
NETFLIX INC Aktie
NIKE INC - CLASS B
NIKE INC - CLASS B Aktie
SHOPIFY A SUB.VTG
SHOPIFY A SUB.VTG Aktie
SOFINA
SOFINA Aktie
TAIWAN SEMICON.MANU.ADR/5
TAIWAN SEMICON.MANU.ADR/5 Aktie
WALT DISNEY INC
WALT DISNEY INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025